+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Acromegaly Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Acromegaly Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Postherpetic Neuralgia - Pipeline Insight, 2025 - Product Thumbnail Image

Postherpetic Neuralgia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
CAR T - Cell Therapy - Competitive landscape, 2023 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
From
From
The State of the Biopharmaceutical Industry 2024 Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2024 Edition

  • Report
  • December 2023
  • 110 Pages
  • Global
From
Drug Formulation Market Report 2025 - Product Thumbnail Image

Drug Formulation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator